Madrigal Pharmaceuticals, Inc. (MDGL)

452.12 -15.04 (-3.22%) USD  |  NASDAQ  |  Oct 13, 16:00
452.18 +0.06 (+0.01%) After-Hours: 20:00
More

Madrigal Pharmaceuticals EPS Diluted (TTM) : -12.88 for June 30, 2026

EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2005. Start Trial.
Date Value
June 30, 2026 -12.88
March 31, 2026 -12.80
December 31, 2025 -12.86
September 30, 2025 -13.01
June 30, 2025 -12.85
March 31, 2025 -18.04
December 31, 2024 -22.11
September 30, 2024 -25.07
June 30, 2024 -25.50
March 31, 2024 -23.08
December 31, 2023 -19.94
September 30, 2023 -19.24
June 30, 2023 -18.64
March 31, 2023 -18.09
December 31, 2022 -17.23
September 30, 2022 -16.03
June 30, 2022 -15.07
March 31, 2022 -14.66
December 31, 2021 -14.61
September 30, 2021 -14.65
June 30, 2021 -14.61
March 31, 2021 -14.07
December 31, 2020 -13.09
September 30, 2020 -11.07
June 30, 2020 -8.706
Date Value
March 31, 2020 -6.812
December 31, 2019 -5.451
September 30, 2019 -4.401
June 30, 2019 -3.567
March 31, 2019 -2.735
December 31, 2018 -2.204
September 30, 2018 -2.126
June 30, 2018 -2.250
March 31, 2018 -2.490
December 31, 2017 -2.54
September 30, 2017 -2.518
June 30, 2017 -3.178
March 31, 2017 -574.04
December 31, 2016 -913.74
September 30, 2016 -1287.17
June 30, 2016 -1294.58
March 31, 2016 -728.28
December 31, 2015 -394.73
September 30, 2015 -27.30
June 30, 2015 -25.20
March 31, 2015 -28.35
December 31, 2014 -31.50
September 30, 2014 -35.70
June 30, 2014 -40.60
March 31, 2014 -43.75

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. 5.923
Insmed, Inc. -4.105
United Therapeutics Corp. 27.96
Karyopharm Therapeutics, Inc. -13.08
ACADIA Pharmaceuticals, Inc. 2.220